ALX Oncology Holdings Inc (ALXO)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -32.22M | -32.2M | -36.78M | -53.28M | -48.02M | -37.76M | -41.53M | -32.57M |
税引前収入 | -30.65M | -30.18M | -34.16M | -50.99M | -45.47M | -35.58M | -39.4M | -30.71M |
純利益 | -30.71M | -30.18M | -34.16M | -50.99M | -45.47M | -35.58M | -39.4M | -30.71M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -32.45M | -32.11M | -36.45M | -53.28M | -47.63M | -37.78M | -41.53M | -32.56M |
EBITDA | -32.11M | -31.99M | -36.57M | -53.07M | -47.82M | -37.55M | -41.31M | -32.34M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 2.07M | 4.8M | 1.18M | 0 | 0 | 0 |
営業利益 | -13.68M | -19.18M | -43.66M | -83.56M | -127.44M | -170.28M |
税引前収入 | -13.69M | -19.21M | -45.5M | -83.48M | -123.42M | -160.81M |
純利益 | -17.4M | -23.27M | -50.94M | -83.46M | -123.48M | -160.81M |
優先配当 | -3.67M | -4.03M | -5.2M | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.836 | -1.118 | -1.279 | -2.056 | -3.022 | -3.228 |
EBIT | -13.69M | -19.19M | -44.69M | -83.47M | -127.7M | -169.89M |
EBITDA | -13.25M | -18.75M | -43.46M | -83.5M | -127.09M | -169.44M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約